Top Markets
Coin of the day
Sensorion SA Sensorion SA

Sensorion SA

ALSEN
Hisse Senetlerindeki Sıralama #13334
Sensorion SA, a clinical-stage biopharmaceutical company, develops drug... Sensorion SA, a clinical-stage biopharmaceutical company, develops drug candidates for the treatment of inner ear disorders in France. The company develops OTOF-GT, a gene therapy development program to restore hearing in people living with Otoferlin deficiency; USHER-T1-GT, a gene therapy development program to for patients suffering from usher syndrome Type 1; and SENS-401, a drug candidate to treat sudden sensorineural hearing loss. Its pipeline also includes various products in development stage for restoring, treating, and preventing inner ear related disorders. The company has a collaboration agreement with Institut Pasteur for gene therapy program for pediatric and adult deafness; and with Sonova Holding AG to introduce genetic analysis for routine diagnosis of progressive hearing loss in adults through a combination of advanced therapeutic interventions and traditional hearing aids. Sensorion SA was founded in 2009 and is headquartered in Montpellier, France.
Hisse Fiyatı
$0.30840035
Piyasa Değeri
$94.37M
Değişim (1 gün)
0.00%
Değişim (1 yıl)
-34.60%
Ülke
FR
Ticaret Sensorion SA (ALSEN)

Kategori

Sensorion SA (ALSEN) için hisse senedi fiyat geçmişi
Gün sonu en yüksek fiyat: $0.30 - 2026-07-01

Gün sonu en düşük fiyat: $4.88 - 2015-04-01
Sensorion SA için hisse fiyatı geçmişi: 2015 - 2026
Yıllık Hisse Fiyatı Performansı
Yıl Performans
2026 (TTM) -14.19%
2025 -35.43%
2024 42.20%
2023 21.00%
2022 -80.41%
2021 12.23%
2020 121.36%
2019 -30.56%
2018 -66.86%
2017 -29.31%
2016 -42.01%
2015 0.00%
Benzer şirketler veya rakiplerin hisse fiyatı
Şirket Hisse fiyatı Değişim 1yıl% Ülke
$49.48 -28.22%
DK
$478.51 2.06%
US
$658.80 16.04%
US
$280.05 40.43%
BE
$868.37 55.00%
NL